Elythea: Maternal Risk Prediction Platform
Elythea, Inc
Solution Overview & Benefits
Elythea's proprietary ML models catch life-threatening obstetric complications (like postpartum hemorrhage, preeclampsia/eclampsia, emergency c-section, preterm labor, and more) as soon as the first visit. The program automatically analyzes relevant demographic and clinical risk factors, flags high-risk patients, and provides evidence-based interventions to prevent the complication altogether.
Elythea has completed prospective international clinical trials across the USA, Cameroon, and Nigeria demonstrating that its models have better performance than the current gold standard clinical methods.
Benefits include:
- Early detection—flags 2–3× more high-risk pregnancies than conventional assessments and 10× sooner.
- Better outcomes—80% reduction in preeclampsia, 68% reduction in hemorrhage, and 45% fewer C-sections in trials.
- Cost-saving—approx. $863 saved per patient through preventive intervention.
- Global reach—used in clinical studies across the U.S., Cameroon, Nigeria, and more.
- EHR integration—works within existing systems like Athena and Epic, ensuring low disruption
History & Development
Founded in 2023 by Reetam Ganguli (formerly studying medicine at Brown University), Elythea is a Y Combinator S23 company focused on maternal health AI. Its platform was validated by large-scale global trials demonstrating superior predictive performance compared to standard risk scoring tools. The team continues collaborating with healthcare providers and payers to scale deployment in both high- and low-resource settings.
Availability
- Available: USA, Nigeria, Cameroon, Uganda, Ghana
Similar solutions...
Get in Touch!
Get in touch with us by filling out the form or emailing us at contact@techxlab.org.
